Table 3.

Toxicity monitoring (n = 39).

Grade
Adverse1234
Eventn (%)n (%)n (%)n (%)
TypeArm
NauseaPoly-E2 (10.5)
Placebo1 (5.0)
Abdominal painPlacebo1 (5.0c)
ALTa increasePoly-E1c (5.3)
ASTb increasePoly-E1c (5.3)
DiarrheaPoly-E1 (5.3)
DizzinessPlacebo1 (5.0)
DyspepsiaPlacebo1 (5.0c)
FatiguePlacebo1 (5.0)
Flu-like syndromePlacebo1 (5.0)
HeadachePlacebo1 (5.0)
MyalgiaPlacebo1 (5.0)
  • aAlanine aminotransferase.

  • bAspartate aminotransferase.

  • cSame patient.